Search - tctmd.com

Displaying 1 - 20 of 304

Sort: Relevancy | Date

News Daily News

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

Yael L. Maxwell

January 07, 2026

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

Presentation TCT 2025

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

The Future of Interatrial Shunting

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

News Daily News

Prophylactic Pacemakers After TAVI Provide Little Benefit: PROMOTE

Michael O'Riordan

September 26, 2025

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement

Presenter: Josep Rodés-Cabau

October 27, 2024

News Daily News

Post-TAVI Neurologic Problems an Ongoing Issue

Todd Neale

August 16, 2024

Podcast TCTMD Talking Points

The VIVA Trial

May 15, 2024

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Presenter: Josep Rodés-Cabau

October 26, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Presenter: Josep Rodés-Cabau

October 24, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

Presentation TCT 2022

The Last Words on Conduction Disturbances

Presenter: Josep Rodés-Cabau

September 17, 2022

News Daily News

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Yael L. Maxwell

July 01, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

Advertisement

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

The Future of Interatrial Shunting

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Prophylactic Pacemakers After TAVI Provide Little Benefit: PROMOTE

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement

Post-TAVI Neurologic Problems an Ongoing Issue

The VIVA Trial

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

The Last Words on Conduction Disturbances

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

More Support for Single Antiplatelet Therapy After TAVI

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content